Lung Cancer Incidence, Mortality, Treatment and Survival in the Republic of Ireland :Lung Cancer Incidence, Mortality PDF Download

Author:
Publisher:
ISBN:
Category : Lungs
Languages : en
Pages : 29

View

Book Description

Author: National Cancer Registry (Ireland)
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 29

View

Book Description

Author: Jonathan M. Samet
Publisher: CRC Press
ISBN: 9780824788537
Category : Medical
Languages : en
Pages : 568

View

Book Description
Providing a historical perspective on the etiology of lung cancer, this comprehensive reference presents an in-depth analysis of the epidemiology of cancer of the lung-describing the current understanding of risk factors and the use of epidemiological data to design programs for the control of this leading cause of death worldwide.

Author: Ireland. National Cancer Registry Board
Publisher:
ISBN:
Category : Medical care
Languages : en
Pages :

View

Book Description

Author: Australian Institute of Health and Welfare
Publisher: AIHW
ISBN: 1742493386
Category : Cancer
Languages : en
Pages : 200

View

Book Description
This report presents the latest national survival and prevalence statistics for cancers in Australia from 1982 to 2010. Survival from cancer is a key indicator of cancer prognosis, control and treatment. It refers to the probability of being alive for a given amount of time after diagnosis and reflects the severity of a cancer diagnosis.

Author: National Cancer Registry (Ireland)
Publisher:
ISBN:
Category : Cancer
Languages : en
Pages : 24

View

Book Description

Author: David W. Donnelly
Publisher:
ISBN:
Category :
Languages : en
Pages : 0

View

Book Description

Author: Poppy E. Deviany
Publisher:
ISBN:
Category :
Languages : en
Pages : 106

View

Book Description
Lung cancer is the second most commonly diagnosed cancer and the leading cause of cancer mortality of both genders in the United States. A recent report suggests that the relative five-year survival rate of lung cancer is only 18%. Studies indicate many factors are associated with the survival of lung cancer patients, including age at diagnosis. It is widely known as a disease of older people, but the literature shows a substantial number of young people have been diagnosed with lung cancer. The literature also indicates that the refusal of recommended treatment contributes to cancer-related death and poorer survival. The objectives of this dissertation were to estimate the survival of lung cancer patients, examine the effect of treatment refusal on survival, and investigate factors associated with treatment refusal. To address these objectives, we conducted our analyses using two large cancer databases: the Veterans Affairs Central Cancer Registry and the National Cancer Database. We performed statistical data analyses using logistic regression, the Kaplan–Meier survival estimator, and Cox regression (proportional hazards regression) method. The results indicate a better five-year survival among younger-onset patients compared with older-onset patients, particularly among early-stage cancer. In the multivariable analyses, treatment refusal was associated with higher mortality risk. Furthermore, our results suggested that patients of older age at diagnosis, female gender, with comorbid conditions, and uninsured status were more likely to refuse recommended lung cancer treatment. In this dissertation, we could not analyze other relevant factors, such as types of comorbidity, patient’s performance status, treatment side effects, family history of lung cancer, and cost of treatment, due to data limitation. Adjusting such factors in future studies will provide a more robust comparison of survival and genetic differences between younger- and older-onset lung cancer cases. Future studies should also examine patients’ and clinical aspects of cancer education and patient–physician communication materials to improve patient acceptance of lung cancer treatment.

Author: Valerio Gristina
Publisher: Frontiers Media SA
ISBN: 2832550533
Category : Medical
Languages : en
Pages : 238

View

Book Description
Lung cancer is still one of the most common malignancies with a high global mortality rate with over 2 million cases confirmed by the World Health Organization in 2018. Although there has been progress in diagnosing and treating lung cancer, patients still have poor prognosis with a 5-year survival rate typically from 4-17% which is dependent on the stage of the cancer and regional differences. The majority of lung cancer patients are at the advanced stages of the disease at the time of their diagnosis and therefore, have less chances of early treatment that could have improved their survival rate. Therefore, early detection of lung cancer remains imperative to improve the prognosis.

Author: Judith Mackay
Publisher: World Health Organization
ISBN: 9789241562096
Category : Business & Economics
Languages : en
Pages : 140

View

Book Description
Research in the past five years suggests a bleak picture of the health dangers of smoking, with tobacco the biggest single killer of all forms of pollution. It is estimated that one person dies every ten seconds due to smoking-related diseases. This publication considers the history and current position regarding tobacco use, as well as providing some predictions for the future of the tobacco epidemic upto the year 2050. It contains a number of full-colour world maps and graphics to illustrate the variations between countries and regions. Issues discussed include: tobacco prevalence and consumption; youth smoking; the economics of tobacco farming and manufacturing; smuggling; the tobacco industry, promotion, profits and trade; smokers' rights; legislative action such as smoke-free areas, tobacco advertising bans and health warnings.